Literature DB >> 2370378

Oral mucosal lesions found in smokeless tobacco users.

D Grady1, J Greene, T E Daniels, V L Ernster, P B Robertson, W Hauck, D Greenspan, J Greenspan, S Silverman.   

Abstract

The risk for oral mucosal lesions associated with use of smokeless tobacco among 1,109 professional baseball players during spring training in 1988 was investigated. Leukoplakia was very strongly associated with use of smokeless tobacco in this population of healthy young men. Of the 423 current smokeless tobacco users, 196 had leukoplakia compared to seven of the 493 nonusers (OR = 60.0, 95% CI = 40.5-88.8). The amount of smokeless tobacco used (in hours per day that smokeless tobacco was held in the mouth), recency of smokeless tobacco use (hours since last use), type (snuff versus chewing tobacco), and brand of snuff used were significantly associated with risk for leukoplakic lesions among smokeless tobacco users. Ninety-eight leukoplakic areas in 92 subjects were biopsied and examined microscopically. All lesions were benign, but one specimen had mild epithelial dysplasia. The long-term significance of leukoplakia in smokeless tobacco users and their relation to oral cancer is not clear.

Entities:  

Mesh:

Year:  1990        PMID: 2370378     DOI: 10.14219/jada.archive.1990.0139

Source DB:  PubMed          Journal:  J Am Dent Assoc        ISSN: 0002-8177            Impact factor:   3.634


  21 in total

1.  Spit (smokeless) tobacco use by high school baseball athletes in California.

Authors:  M M Walsh; J Ellison; J F Hilton; M Chesney; V L Ernster
Journal:  Tob Control       Date:  2000       Impact factor: 7.552

2.  Should doctors advocate snus and other nicotine replacements? No.

Authors:  Alexander W Macara
Journal:  BMJ       Date:  2008-02-16

3.  Smokeless tobacco use and periodontal health in a rural male population.

Authors:  Yong H Chu; Dimitris N Tatakis; Alvin G Wee
Journal:  J Periodontol       Date:  2010-06       Impact factor: 6.993

4.  Smokeless tobacco cessation intervention for college athletes: results after 1 year.

Authors:  M M Walsh; J F Hilton; C M Masouredis; L Gee; M A Chesney; V L Ernster
Journal:  Am J Public Health       Date:  1999-02       Impact factor: 9.308

Review 5.  Personalized periodontal treatment for the tobacco- and alcohol-using patient.

Authors:  Mark I Ryder; Elizabeth T Couch; Benjamin W Chaffee
Journal:  Periodontol 2000       Date:  2018-10       Impact factor: 7.589

6.  Bacillus species are present in chewing tobacco sold in the United States and evoke plasma exudation from the oral mucosa.

Authors:  Israel Rubinstein; Gerald W Pedersen
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

7.  Electron Microscopic Analysis of Surface Inorganic Substances on Oral and Combustible Tobacco Products.

Authors:  Mary M Halstead; Clifford H Watson; R Steven Pappas
Journal:  J Anal Toxicol       Date:  2015-08-17       Impact factor: 3.367

8.  Patterns and correlates of spit tobacco use among high school males in rural California.

Authors:  Stuart A Gansky; James A Ellison; Catherine Kavanagh; Umo Isong; Margaret M Walsh
Journal:  J Public Health Dent       Date:  2009       Impact factor: 1.821

9.  Spit (Smokeless)-Tobacco Use by Baseball Players Entering the Professional Ranks.

Authors:  Jeff Cooper; James A. Ellison; Margaret M. Walsh
Journal:  J Athl Train       Date:  2003-06       Impact factor: 2.860

10.  Modulation of annexin I and cyclooxygenase-2 in smokeless tobacco-induced inflammation and oral cancer.

Authors:  Jamboor K Vishwanatha; Ryan Swinney; Abhijit G Banerjee
Journal:  Mol Cell Biochem       Date:  2003-06       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.